PathAI

PathAI is a Boston, MA, company founded in 2016 that develops AI-powered pathology tools, including the FDA-cleared AISight digital pathology platform, for biopharma companies and pathology laboratories. It supports biomarker discovery and drug development with AI models, a CAP/CLIA-certified histopathology lab and a pathologist network, and has agreed to be acquired by Roche.